1. A family case with germlineTSC1and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis
   Hiromasa Sakamoto et al, 2018, Journal of Clinical Pathology CrossRef
2. Genome‐wide screening identifies novel genes and biological processes implicated in cisplatin resistance
   Tengyu Ko et al, 2019, The FASEB Journal CrossRef
3. mtDNA mutations in cancer
   Giulia Girolimetti et al, 2020, The Human Mitochondrial Genome CrossRef
4. Potential role of heteroplasmic mitochondrial DNA mutations in modulating the subtype-specific adaptation of oral squamous cell carcinoma to cisplatin therapy
   Amnani Aminuddin et al, 2024, Discover Oncology CrossRef
5. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
   Amnani Aminuddin et al, 2020, Scientific Reports CrossRef
6. Hierarchical nanoclusters with programmed disassembly for mitochondria-targeted tumor therapy with MR imaging
   Congkun Xie et al, 2021, Biomaterials Science CrossRef
7. Advanced technological tools to study multidrug resistance in cancer
   Luca Andrei et al, 2020, Drug Resistance Updates CrossRef
8. The Role of Mitochondrial DNA Variation in Drug Response: A Systematic Review
   Samantha W. Jones et al, 2021, Frontiers in Genetics CrossRef
9. Pulmonary Diseases, a Matter of Time
   Cecilia G. Sanchez, 2017, Circadian Rhythms and Their Impact on Aging CrossRef
10. Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells
    Jing-jing Mou et al, 2018, Biomedicine & Pharmacotherapy CrossRef